We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sekisui XenoTech Appoints New COO

News   Oct 20, 2017

 
Sekisui XenoTech Appoints New COO
 
 
 

RELATED ARTICLES

A Novel Epstein-Barr Virus-specific T Cell Therapy for Progressive MS

News

Mounting evidence shows that Epstein-Barr virus (EBV) plays a role in the pathology of multiple sclerosis. Consequently, an EBV-specific T Cell therapy has been developed to combat MS, and initial clinical trial results are promising.

READ MORE

Up-scaling Production of MiRNA-enriched Extracellular Vesicles

News

Overexpressing an miRNA precursor in cells increases the specific miRNA content in extra-cellular vesicles, a potential new mode of drug delivery vehicle.

READ MORE

Epigenetic Treatments Could Trigger Aggressive Tumors

News

A team headed by ICREA researchers Salvador Aznar Benitah and Fran Supek concludes that care should be taken with drugs that inhibit epigenetic factors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE